Clinical trial
VIVITROL® (Naltrexone for Extended Release Injectable Suspension (XR-NTX)) for Opioid Dependent Inmates Released From Prison
NCT01563718 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VIVITROL® (Naltrexone for Extended Release Injectable Suspension (XR-NTX)) for Opioid Dependent Inmates Released From Prison
- Lead sponsor
- Rhode Island Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- August 31, 2015
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.